Marker Therapeutics, Inc. (MRKR)
1.34
+0.02
(+1.52%)
USD |
NASDAQ |
Mar 20, 16:00
1.33
-0.01
(-0.75%)
After-Hours: 20:00
Marker Therapeutics Research and Development Expense (Quarterly) : 2.141M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Viridian Therapeutics, Inc. | 89.09M |
| ACADIA Pharmaceuticals, Inc. | 84.76M |
| Kiniksa Pharmaceuticals International Plc | 34.49M |
| electroCore, Inc. | 0.92M |
| Agenus, Inc. | 7.511M |